Skip to content
preclinicalImmune & Inflammation

Human Alpha-Defensin

Also known as: HNP-1, Human Neutrophil Peptide-1, Alpha-Defensin-1, DEFA1, HNP-2, HNP-3

Human alpha-defensins (HNP-1 through HNP-4) are small cationic antimicrobial peptides stored in the azurophilic granules of neutrophils. HNP-1 is the most abundant, comprising approximately 30-50% of total neutrophil granule protein. These 29-30 amino acid peptides form the first line of innate immune defense against invading bacteria, fungi, and enveloped viruses by disrupting microbial membranes.

3 cited references·6 researched benefits

Quick Answer

Human alpha-defensins are 29-30 amino acid antimicrobial peptides released from neutrophil granules during infection. HNP-1 is the most studied member, directly killing bacteria, fungi, and enveloped viruses through membrane disruption. Alpha-defensins also bridge innate and adaptive immunity by recruiting T-cells and dendritic cells to infection sites. They are being investigated as templates for novel antibiotic development. Research remains preclinical with no therapeutic formulations approved.

Key Facts

Mechanism
Alpha-defensins kill pathogens primarily through electrostatic attraction to negatively charged microbial membranes, followed by insertion and pore formation that causes membrane permeabilization and cell lysis. They form a characteristic triple-stranded beta-sheet structure stabilized by three intramolecular disulfide bonds. Beyond direct antimicrobial activity, HNP-1 acts as a chemoattractant for monocytes, naive T-cells, and immature dendritic cells, bridging innate and adaptive immunity. They also stimulate IL-8 secretion from epithelial cells, amplifying the inflammatory response at infection sites.
Research Status
preclinical
Half-Life
Variable (tissue-dependent); rapidly cleared from circulation
Molecular Formula
C₁₅₀H₂₂₅N₄₅O₃₉S₆
Primary Use
Immune & Inflammation
Table of Contents

Benefits

  • Broad-spectrum antimicrobial activity against gram-positive and gram-negative bacteriastrong
  • Antifungal activity against Candida species and other pathogenic fungistrong
  • Antiviral activity against enveloped viruses including HIV and influenzamoderate
  • Bridges innate and adaptive immunity by recruiting dendritic cells and T-cellsmoderate
  • Template for development of novel antimicrobial drugs to combat antibiotic resistancepreliminary
  • Potential biomarker for inflammatory and infectious diseasesmoderate

Dosage Protocols

RouteDosage RangeFrequencyNotes
Research use only1–50 mcg/mL (in vitro)VariableNo established human dosing; used in laboratory research and as a template for drug design

Medical disclaimer

Dosage information is provided for educational reference only. Always follow your prescriber's instructions and consult a qualified healthcare provider before starting any peptide protocol.

Side Effects

  • Cytotoxic to mammalian cells at high concentrationsserious
  • Pro-inflammatory effects when overexpressed in tissuescommon
  • Potential contribution to autoimmune pathology at elevated systemic levelsserious
  • Hemolytic activity at supratherapeutic concentrationsrare

Frequently Asked Questions

What is the difference between alpha-defensins and beta-defensins?
Alpha-defensins and beta-defensins differ in their disulfide bond pairing pattern, source cells, and tissue distribution. Alpha-defensins (HNP-1 through HNP-4) are primarily stored in neutrophil granules and released during degranulation at infection sites. Beta-defensins (hBD-1, hBD-2, hBD-3) are produced by epithelial cells lining the skin, respiratory tract, and gastrointestinal tract, providing a constitutive antimicrobial barrier. Both share a similar overall fold but have distinct antimicrobial spectra.
Can alpha-defensins be used as antibiotics?
Alpha-defensins themselves are not suitable as systemic antibiotics due to their cytotoxicity to mammalian cells at antimicrobial concentrations, rapid proteolytic degradation, and salt sensitivity. However, they serve as important templates for designing synthetic antimicrobial peptides that retain the killing mechanism while reducing toxicity. Several defensin-derived compounds are in preclinical development as topical antimicrobials and anti-biofilm agents.
How do alpha-defensins relate to immune health?
Alpha-defensin levels are a direct indicator of neutrophil activity and innate immune function. Low levels may indicate neutropenia or immune deficiency, while elevated levels are seen in infections, inflammatory conditions, and autoimmune diseases. Fecal alpha-defensin levels are used as a biomarker for intestinal inflammation, particularly in differentiating between Crohn's disease and other gastrointestinal conditions.

References

  1. 1
    Defensins: antimicrobial peptides of innate immunity(1985)PubMed ↗
  2. 2
    Defensins: antimicrobial peptides of vertebrates(2007)PubMed ↗
  3. 3
    Human alpha-defensin HNP1 increases HIV-1 infectivity in vitro(2005)PubMed ↗

Latest Research

Last updated: 2026-02-19